Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101318146A reveals a novel organocatalyst enabling dual-handed synthesis of gamma-nitro ketones with high enantioselectivity, offering cost-effective solutions for API manufacturing.
Patent CN101781246A details a high-yield two-step synthesis for Aripiprazole using azeotropic solvents, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113214267B reveals a novel one-step crystallization method for eszopiclone, offering high purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Advanced semi-synthetic route for Vinpocetine ensuring high purity and yield. Cost-effective manufacturing solution for global pharmaceutical supply chains.
Patent CN106831632B reveals metal-free oxidation for 4H-3,1-benzoxazine. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Novel catalyst-free route for Tadalafil intermediate ensures high purity and supply stability for global pharmaceutical manufacturing partners seeking reliable scale-up.
Patent CN104151249B details a high-purity chiral resolution method using camphorsulfonic acid, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel DABCO-catalyzed route for 6-nitropyridin-3-ol. High yield, scalable pharma intermediate production. Reliable supply chain solutions.
Novel patent CN103254179A details a cost-effective Cytosine-based synthesis for Avanafil, offering superior scalability and supply chain reliability for API manufacturers.
Patent CN1300143C reveals a DMSO-based purification method achieving 99.9% purity. Offers cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN110790752B reveals a metal-free acid-catalyzed route for isoquinoline substituted flavones, offering significant cost reduction in API manufacturing and streamlined supply chains.
Patent CN111004179B details a high-purity resolution method for 5'-methoxylaudanosine, offering superior yield and optical purity for neuromuscular blocker synthesis.
Novel phase-transfer catalyst method for Ivabradine synthesis. Reduces reaction time, improves purity, avoids chromatography. Reliable supply chain partner for commercial scale.
Patent CN110526859A reveals high-yield route for Revefenacin intermediates offering cost reduction in API manufacturing and supply chain reliability for global buyers.
Patent CN106631903A reveals advanced chiral hydrogenation for LCZ-696 intermediates. Enhances purity and reduces costs for pharmaceutical intermediates manufacturing supply chains.
Patent CN111411095B discloses a novel recombinant (R)-ω-transaminase mutant with high activity and stereoselectivity for efficient sitagliptin intermediate production, ensuring supply chain stability.
Novel composite catalyst method reduces time and cost for Ivabradine manufacturing ensuring high purity and supply chain reliability for global partners.
Patent CN112094856B discloses high-efficiency transaminase mutants for sitagliptin synthesis, achieving >99.95% e.e. and enabling significant cost reduction in API manufacturing.
Patent CN106086089B details enzymatic route for high purity (R)-citronellal. Offers green manufacturing and supply chain stability for global fragrance and pharma intermediates.
Patent CN1842523A details a novel asymmetric hydrogenation process for enantiomerically pure beta-amino alcohols, offering significant cost reduction in API manufacturing.